Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brachytherapy use in cervical cancer: a narrative review.

Gynecology and pelvic medicine·2026
Same author

Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.

Neuro-oncology practice·2026
Same author

GBM-Dx SIGNAL: Blood transcriptomics complementing neuroimaging to differentiate glioblastoma recurrence from treatment effects.

Genes & diseases·2026
Same author

SARS-CoV-2 infection reduces the number of spermatogonial stem cells and dysregulates the transcriptional landscape of the human testis.

Research square·2026
Same author

Tenzingplasty for symptomatic, non-occlusive intracranial atherosclerotic disease after maximal medical therapy failure.

Journal of cerebrovascular and endovascular neurosurgery·2026
Same author

Short-course radiotherapy with or without temozolomide in elderly patients with newly diagnosed glioblastoma: a time-to-event meta-analysis of overall and progression-free survival.

Journal of neuro-oncology·2025

Related Experiment Video

Updated: Mar 23, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

719

Multiple dural-based hemangiopericytomas.

Edana Stroberg1, David H Uhrbrock1, Frank Harris1

  • 1Department of Pathology (Stroberg, DiPatre), Department of Diagnostic Radiology (Uhrbrock), Department of Neurosurgery (Harris, Fonkem), and Department of Radiation Oncology (Mutyala), Baylor Scott & White Healthcare, Temple, Texas.

Proceedings (Baylor University. Medical Center)
|April 2, 2016
PubMed
Summary

A patient with a dural-based hemangiopericytoma (HPC) experienced a recurrence and a new tumor. Both tumors were confirmed as HPCs, highlighting the potential for late recurrence and new primary tumors.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
08:26

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

8.6K
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

10.4K

Related Experiment Videos

Last Updated: Mar 23, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

719
A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
08:26

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

8.6K
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

10.4K

Area of Science:

  • Neuropathology
  • Neurosurgery
  • Oncology

Background:

  • Dural-based hemangiopericytomas (HPC) are rare tumors.
  • Complete resection and adjuvant radiation therapy are standard treatments.
  • Long-term surveillance is crucial due to potential for recurrence.

Observation:

  • A 57-year-old man with a resected dural-based HPC developed a recurrent tumor 10 years post-treatment.
  • A second, distinct HPC appeared in the contralateral middle cranial fossa.
  • Both recurrent and new tumors required surgical intervention.

Findings:

  • Histological examination confirmed both the recurrent and the new mass as hemangiopericytomas.
  • The recurrent tumor was located near the initial tumor site.
  • The new tumor was a separate entity in the right middle cranial fossa.

Implications:

  • This case underscores the possibility of late recurrence of hemangiopericytoma.
  • It also suggests the potential for developing new, independent hemangiopericytomas years after initial treatment.
  • Long-term, vigilant follow-up is essential for patients treated for dural-based HPCs.